medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2010, Number 1

<< Back Next >>

Rev Med UV 2010; 10 (1)

Smoking and oral cancer: A theoretical review

Nachón GMG, García-Rivera ME, Nachón-García FJ, Hernández-Parra TG, Hernández-Lira G

Language: Spanish
References: 57
Page: 30-37
PDF size: 321.25 Kb.


ABSTRACT

Smoking is a chronic disease caused by the habit of smoking, being nicotine one of its main active components and accountable for addiction. In addition to nicotine, tobacco contains substances such as: N-nitrosamine, N-nitrosonornicotine and 4(Methyl nitrosamine)-1-(3-Pyridyl)-1-Butanone, which are accountable for, mainly, the origin of the pre-malignant and malignant processes in the oral cavity. The tendency of smoking in Mexico is that it is started each time at a younger age, an increase in the prevalence of women and a higher consumption in the rural area. It is associated to respiratory diseases, cancer in oral cavity, larynx and esophagus, among others. There are different oral manifestations in smokers being squamous cell carcinoma the malignant neoplasia that is more frequently found in the oral cavity of smokers. The most effective diagnostic method is biopsy. The treatment of the disease is varied and it almost always involves the combination of surgery (when possible), radiotherapy and chemotherapy, in addition to these therapies having side effects to the patient. The Stomatology plays a fundamental role in the early diagnosis and the prevention of this disease, given that it is his task to detect any lesion in an incipient state therefore simplifying treatment and improving the quality of life of the patient, however, much more important than detecting the lesion it the prevention of its occurrence by guiding the population and fighting the risk factors. The objective of this article is the theoretical revision of the association between tobacco and the existence of oral cancer.


REFERENCES

  1. SSA/CONADIC. Programa Nacional Contra las adicciones. Programa contra el tabaquismo. Secretaria de Salud- Consejo Nacional contra las adicciones; 2000: P. 110.

  2. Kuri-Morales PA, Jesús Felipe González-Roldán JF, Hoy MJ, Mario Cortés-Ramírez M. Epidemiologias del tabaquismo en México. Salud Pública de México 2006; 48 (suppl 1): 91-98.

  3. Quintana-Díaz JC, Fernández-Fregio MJ, Laborde Ramos R. Factores de riesgo de lesiones premalignas y malignas bucales. Rev. Cubana Estomatol [serial on line] 2004 sep-dic [citado en 2010 sep]; 1 (1): [24 screens]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S0034-75072004000300007

  4. Lence J, Rodríguez A, Santana JC, Fernández L. Programa del diagnóstico precoz del cáncer bucal. Resultado y perspectivas. Rev Cubana Med Gen Integr 1994; 10 (3): 230-34.

  5. León E, Romero MC, Ferrer I, Fatjo M. Pesquisaje de lesiones premalignas y malignas de la cavidad bucal. Rev. Cubana Med Gen Integr 1996; 12(3): 216-21.

  6. Rodríguez A, Delgado L. Vigilancia y evaluación de la salud bucal. Método de observación y control. Rev Cubana Estomatol 1995; 32(1): 9-15.

  7. Nicot RF, Delgado I, Soto G. Factores de riesgo en las lesiones premalignas y malignas del complejo bucal. Rev Cubana Estomatol 1995; 32(2): 60-3.

  8. Camacho R y cols. El programa nacional de control de cáncer en Cuba. Rev Cubana Med Gen Integr 1994; 10(3): 215-19.

  9. La Vecchia C y cols. Trends in cancer mortality in the USSR, 1965- 1990. Int J Cancer 1994; 56: 31-39.

  10. World Cancer Research Fund. Food, nutrition and the prevention of cancer: A global perspective. American Institute of Cancer; 1997: 670.

  11. American Psychiatric Association. Manual Diagnóstico y estadístico de los trastornos mentales. Barcelona: Ed. Elsevier Masson; 2002.

  12. Martín Ruiz A y cols. Efectos tóxicos del tabaco. Rev Toxicol 2004; 21: 64-71.

  13. Doll R, Hill A. Smoking and carcinoma of the lung: Preliminary report. BMJ 1950; 2: 739-48.

  14. Levin M, Goldstein H, Gerhardt P. Cancer and tobacco smoking: Preliminary report. JAMA 1950; 143: 336-338.

  15. Wynder E, Goodman M. Smoking and lung cancer: Some unresolved issues. Epidemiol Rev 1983; 5: 177-207.

  16. Wynder E, Graham E. Tobacco smoking as a possible ethiological factor in bronchiogenic carcinoma. JAMA 1950; 143: 329-33.

  17. Wynder E, Goodman M. Smoking and lung cancer: Some unresolved issues. Epidemiol Rev 1983; 5: 177-207.

  18. Boyle P. Cancer, cigarette smoking and premature death in Europe: A review including the Recommendations of European Cancer Experts Consensus Meeting [serial on line] 1996 May [citado en 2010 Sep]; 1(1): [24 screens]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9194026

  19. Pershagen G, Smokeless tobacco B. Med Bull 1996; 52(1): 50-57.

  20. Hoffmann D, y Djordjevic MV. Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res. 1997; 11(3): 322-329.

  21. Schulz M, Reichart PA, Ramseier CA, Bornstein MM. Smokeless tobacco: a new risk factor for oral health: A review Schweiz Monatsschr Zahnmed. 2009; 119(11): 1095-109.

  22. Instituto Nacional de Cancerología. El Tabaquismo y sus efectos en la cavidad oral- Epidemiología descriptiva del cáncer de cavidad bucal. Rev Inst Nal Cancerol Méx 1997; 43.

  23. Patricia Pérez Ríos Ma, Pérez Carrillo E, Becerril Ramírez A y Ocampo Ocampo A. Importancia de la Prevención y Detección de las lesiones bucales por uso de tabaco. Serv de Estomatología de la Unidad de Dermatología Hospital general de México 2003.

  24. Departamento de Salud y Servicios Humanos de los Estados Unidos / Instituto Nacional de Investigación Dental y Craneofacial / Institutos Nacionales de la Salud. La Salud Oral en los Estados Unidos: Informe del Cirujano General Resumen Ejecutivo. Rockville: MD; 2000.

  25. Squier CA, Mantz MJ, Wertz PW. Effect of menthol on the penetration of tobacco carcinogens and nicotine across porcine oral mucosa ex vivo. Nicotine Tob Res 2010; 12(7): 763-7.

  26. Qandil R, Sandhu HS, Matthews DC. Tobacco smoking and periodontal diseases. J Can Dent Assoc 1997; 63(3): 187-92, 194-95.

  27. Tipton DA, y Dabbous MK. Effects of nicotine on proliferation and extracelular matrix production of human gingival fibroblast in vitro. J Periodontology 1995; 62(12): 1056-64.

  28. Seow WK y cols. Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 1994; 18(2): 119-127.

  29. Saap Philip J, Eversole Lewis R, y Wysocki George P. Patología Oral y Maxilofacial Contemporánea. Madrid: Harcourt Brace; 1998.

  30. Regezi, Joseph A, y Sciubba J. Patología Bucal. 2ª Edición. México: Mc Grawn-Hill Interamericana; 1995. P. 641

  31. Shaffer WG, Levy BM, y Hine MK. Tratado de Patología Bucal. 2ª Edición. México(DF): Interamericana; 1986. P. 940.

  32. Murrah VA , Gilchrist EP, y Moyer MP. Attenuation of the natural course of herpes simplex virus infection in human oral epithelial cell cultures by smokless tobacco extracts suggests the possibility of a synergistic mechanism for carcinogenesis. Oral Surg/ Oral Med/ Oral pathol/ Oral Radiol/ Endod 1996; 81(1): 63-9.

  33. Nelson Lobos JF. Cáncer y precáncer de la mucosa oral. Medicina oral, patología oral y cirugía bucal [serial on line] 2006 Mar [citado en 2010 ene]; 1 (1): [24screens]. Disponible en: http://www.medicinaoral.cl/pdf/Cancer%20y%20Pre%20cancer%20 de%20la%20mucosa%20oral.pdf

  34. Villarroel DM, Aguirre UJM. Cáncer y precáncer oral. Aspectos clinicopatológicos y moleculares con implicación pronostica. En: Mosqueda TAA, editor. Clínicas oncológicas de Iberoamérica. Tópicos selectos de oncología bucal. México(DF): PDESA; 2008. P. 81-97.

  35. Warnakulasuriya S. Global trends in the epidemiology of oral cancer; the current position. Oral Oncol 2005; 1 (Abstract K-1): 27.

  36. Gallegos Hernández JF. Lesiones preneoplásicas de la cavidad bucal: detección y diagnóstico oportuno. Cir Ciruj 2008; 76 (3): 197-8.

  37. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Head and Neck Cancers (programa de computador). Version. 1. 2009 National Comprehensive Cancer Network; 2009.

  38. Posner M. Head and neck cancer. En: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia (Pa): Saunders Elsevier; 2007.

  39. Boyle JO y cols. Effects of cigarette smoke on the human oral mucosal transcriptome. Cancer Prev Res 2010; 3(3): 255-8.

  40. Singh P, Warnakulasuriya S. The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit. Br Dent J 2006; 201: 717-20.

  41. Gillison ML y cols. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.

  42. Santana JC. Factores asociados al desarrollo del carcinoma epidermoide bucal. En: Facultad de Odontología, Estado de México: Universidad Autónoma del Estado de México Ofedo/udual; 1991. p. 103

  43. National Cancer Institute. Estadios del cáncer del labio y la cavidad oral. [serial on line] 2009 Ago [citado 30 Nov 2009]; 1 (1): [24screens]. Disponible en: URL:http://www.cancer.gov/espanol/ pdq/tratamiento/labio-y-cavidad-oral/Patient/page2

  44. García García V, Bascones Martínez A. Cáncer oral: puesta al día. Update in oral cancer. Av. Odontol estomatol 2009; 30(5): 239-248.

  45. Shah Jatin P, Gil Ziv, Rapidis Alexander. Current concepts in management of oral cancer-Surgery. Oral Oncology, 2009; 45: 394- 401.

  46. Martínez Gil DC, Díaz Ramos AG, Caballero Henriquez G. Carcinoma Epidermoide Bucal. 16 de Abril Revista Científica Estudiantil de ciencias medicas de cuba 2010; 230.

  47. Wolf G, Philp D. The effect of low and high doses of β-carotene and exposure to cigarette smoke on the lungs of ferrets. Nutrition Reviews 2002; 60(3): 88-90

  48. Calsina G, Ramón JM, Echevarria JJ. Effects of smoking on periodontal tisúes. J Clin Periodontal 2002; 29(8): 771-6.

  49. Zappacosta B y cols. Inhibition of salivary enzymes by cigarette smoke and the protective role of glutathione. Hum Exp Toxicol 2002; 21(1): 7-11.

  50. Kolson H. Epidermoide carcinoma of the floor of the mouth, Analysis 108 cases. Aren Otolaringol 1993; (8): 280-3.

  51. Keller AZ, Terris M. The association of alcohol and tobacco with cáncer of the mouth and pharyng. AMJ Pub Heath 1985; 55(10): 1578-80.

  52. Worman LH. Carcinoma on the lip. Am J Surg 1975; 130: 470-4.

  53. López Chaguín A. Factores de riesgo etiopatogénicos del carcinoma verrugoso de cavidad bucal. Acta Odontológica Venezolana 2000; 38(2): 9-14.

  54. Santana Garay Julio C. Prevención y Diagnóstico del cáncer Bucal. La Habana: Editorial Ciencias médicas; 2002.

  55. Catalán V y cols. Carcinoma epidermoide en cavidad oral. 2007.

  56. World Health Organization classification of tumours. Pathology and genetics of tumours of the head and neck. En: Barnes L, Eveson JW, Reichart PA, et al., eds. Odontogenic tumours. Lyon: IARC; 2005. P. 283–327.

  57. Tovar-Guzmán VJ, Barquera S, López-Antuñano FJ. Tendencias de mortalidad por cánceres atribuibles al tabaco en México. Salud Publica Mex 2002; 44 supl 1:S20-S28.




2020     |     www.medigraphic.com